Karyopharm Therapeutics Inc. (KPTI) Plunges 6.65%

Karyopharm Therapeutics Inc. (KPTI) Plunges 6.65%

Karyopharm Therapeutics Inc. (KPTI) had a rough trading day for Friday December 06 as shares tumbled 6.65%, or a loss of $-1.16 per share, to close at $16.29. After opening the day at $17.61, shares of Karyopharm Therapeutics Inc. traded as high as $17.69 and as low as $15.10. Volume was 2.77 million shares over 19,495 trades, against an average daily volume of n/a shares and a total float of 62.79 million.

As a result of the decline, Karyopharm Therapeutics Inc. now has a market cap of $1.02 billion. In the last year, shares of Karyopharm Therapeutics Inc. have traded between a range of $18.70 and $3.92, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.

Karyopharm Therapeutics Inc is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. The pipeline products of the company include Oral Selinexor, Oral Eltanexor, Oral Dual Inhibitor of PAK4 and NAMPT and Oral Verdinexor.

Karyopharm Therapeutics Inc. is based out of Newton, MA and has some 332 employees. Its CEO is Michael G. Kauffman.

Share:
Scroll Up
error: Content is protected !!